Toward a Blended Ontology: Applying Knowledge Systems to Compare Therapeutic and Toxicological Nanoscale Domains by Grulke, Christopher M. et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 308381, 9 pages
doi:10.1155/2012/308381
Research Article
Towarda BlendedOntology:ApplyingKnowledgeSystemsto
Compare Therapeutic and Toxicological Nanoscale Domains
Christopher M. Grulke, Michael-Rock Goldsmith, and DanielA. Vallero
National Exposure Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA
Correspondence should be addressed to Daniel A. Vallero, vallero.daniel@epa.gov
Received 3 October 2011; Accepted 7 January 2012
Academic Editor: P. Bryant Chase
Copyright © 2012 Christopher M. Grulke et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Bionanomedicine and environmental research share need common terms and ontologies. This study applied knowledge systems,
data mining, and bibliometrics used in nano-scale ADME research from 1991 to 2011. The prominence of nano-ADME in
environmental research began to exceed the publication rate in medical research in 2006. That trend appears to continue as a result
of the growing products in commerce using nanotechnology, that is, 5-fold growth in number of countries with nanomaterials
research centers. Funding for this research virtually did not exist prior to 2002, whereas today both medical and environmental
research is funded globally. Key nanoparticle research began with pharmacology and therapeutic drug-delivery and contrasting
agents, but the advances have found utility in the environmental research community. As evidence ultraﬁne aerosols and aquatic
colloids research increased 6-fold, indicating a new emphasis on environmental nanotoxicology. User-directed expert elicitation
from the engineering and chemical/ADME domains can be combined with appropriate Boolean logic and queries to deﬁne the
corpus of nanoparticle interest. The study combined pharmacological expertise and informatics to identify the corpus by building
logical conclusions and observations. Publication records informatics can lead to an enhanced understanding the connectivity
between ﬁelds, as well as overcoming the diﬀerences in ontology between the ﬁelds.
1.Introduction
The hazard of a chemical compound largely depends on its
product formulation (i.e., an impregnated solid suspension
versus a chemical solution). Recently, there has been much
interest in the role that the size of a particle plays in chemical
hazard and exposure potential [1], such as the degree to
which very small particles cause greater chemical risk than
larger particles with the same chemical composition. Both
nanoparticles and derivative nanomaterials are pervasive
and growing at a rate of over 243 new products per year
worldwide. It is currently estimated that 1317 nanoproducts
are manufactured by 587 companies in over 30 countries.
Thesec onsumerpr oductsspansev eralmajorcat egories(e.g.,
health and ﬁtness, home and garden, automotive, food and
beverage, crosscutting, electronics and computers, appli-
ances, and goods for children) [2], yet their full impact on
product life-cycle and human health still remains poorly
understood due to a paucity of harmonized standards for
safety, environmental impacts, and human health threats.
In fact, there is still some dispute over what should be
deemed a nanoparticle [3]. Current standards in biomedi-
cine and environmental contamination deﬁne nanoparticles
as being <100nm in at least one dimension. Whereas such
dimensional thresholds between nanoscale and bulk mate-
rials are useful for research and scientiﬁc inquiry, they are
not completely applicable to toxicology and risk assessment.
When looking at a particle as a whole, its dimensions may
not meet the above criteria for a nanoparticle while its
construction may have important nanoscale variability that
requires it be studied as a nanoparticle. As evidence, take
a nanoparticle composite with two distinct compartments:
surface and core. These particles may change in time and
space, so that the core becomes the surface with time, as the
original surface is degraded (e.g., during metabolism and
environmental degradation). Such particles constituencies
(i.e., surface versus core) are therefore key in determining
eﬃcacy and toxicity as a function of time and space, there-
by validating the need for studying such a particle using2 Journal of Biomedicine and Biotechnology
nanoscale techniques though its overall dimensions need not
be <100nm.
Setting the deﬁnition of a nanoparticle aside, the federal
government of the United States has with the creation of
the National Nanotechnology Initiative (NNI—see also:
http://www.nano.gov/) identiﬁed a need for the organiza-
tional framework to coordinate nanorelated research eﬀorts
and domains among the federal agencies. The eight major
research areas are the following: (1) fundamental nanoscale
phenomena and processes, (2) nanomaterials, (3) devices
and systems, (4) instrumentation and standards, (5) na-
nomanufacturing, (6) facilities and acquisitions, (7) envi-
ronment, health, and safety, and (8) educational and soci-
etal dimensions. Interestingly, the most impactful ﬁelds of
research appear to be aggregated under a single consolidated
area: environment, health, and safety. This choice to aggre-
gate such ﬁelds is one that should be scrutinized further.
In a sense, researchers advancing therapeutics investigate
similar phenomena as researchers aiming to improve the
understandingof environmentalxenobiotics,butin opposite
directions. That is, both assess and address the factors that
govern the dose-response characteristic of the material and
the risks presented by an agent, whether it is chemical,
or physical. However, biomedicine is looking for ways to
improve the eﬃcacy of a substance while environmental tox-
icologists are searching for ways to prevent a xenobiotic from
having biological eﬀects.
According to the US Environmental Protection Agency’s
(EPA) white paper on nanotechnology, the primary research
targetforabsorption,distribution,metabolism,andelimina-
tion(ADME)researchofnanoparticlesisecologicalrisk(i.e.,
mainly focused on nonhuman species). In addition, lessons
learned from computational toxicology in other agencies
such as the U.S. Food and Drug Administration (FDA) or
on methods gleaned from natural or incidental particulate
matter may prove to be useful to ﬁll the data gaps for these
emerging materials [5]. However, such hypotheses cannot
be tested without ﬁrst identifying the landscape of available
research. Hence, informatics and other knowledge tools pro-
vide a means of assessing the growth, extent, and congruence
of these research domains addressing nanomaterials.
Drug delivery concepts can, in theory, be applied to
toxicology models, such as the need to keep a substance that
is eﬃcacious in certain tissue from reaching other tissues
for which it is toxic (i.e., controlled dose, pharmacokinetics,
or toxicokinetics). For example, liposomes are developed
for drug delivery based on their ability to evade immune
response and enabling bioavailability of the drug to the tar-
get site. Both the biomedical and environmental scientiﬁc
communities are seeking better models for pharmacokinetic
and dynamic (PBPK/PD) behavior of nanoparticles. These
models should be built using the expertise of both con-
tingents as the same ADME processes are in force. Fur-
ther, emergent materials, including nanoparticles, have at-
tracted considerable attention from scientists from the expo-
sure and health hazards communities alike. The source of
these emerging materials in products, and their overall envi-
ronmental fate and transport, environmental degradation,
Table 1: Comparison table of critical factors at play in nanotox-
icology versus toxicity of bulk material of identical composition
(reproduced from: [4]).
Bulk properties Nanoscale properties
Chemical composition Structure (nanostructure)
Dose (mass concentration) Particle concentration
Exposure route Size distributions
Reactivity Particle numbers
Conductivity Aggregation/agglomeration
Morphology Surface adsorb ability
Physical form Surface area
Impurities Surface charge
Solubility Self-assembly
Quantum eﬀects
biodegradation, biological uptake and disposition, and ef-
fects remains poorly characterized [5].
Usually,thetoxicity,ADME,andotherhazardsassociated
with chemical ingredients are a function of the physical
composition of thesubstance. This means thatthe properties
of both the surface and the substance core help to determine
the chemical risk. For example, surface properties drive the
mobility and toxicity of engineered nanomaterials/particle,
but the makeup of the material construct that has been
coated is also important. To this extent it has become more
apparent that there are signiﬁcantly more than the nine
factors commonly used for bulk materials that aﬀect nano-
material ADME and toxicity. Some of these nanomaterial
speciﬁc factors are listed in Table 1.
Chemical manufacturers, pharmaceutical companies,
and environmental researchers all share interest in the char-
acteristics of nanoparticles that may allow them to “hide”
from physiological processes as they ﬁnd their way to the
target cells. For example, nanoparticles for drug delivery
consist of various biological substances like albumin, gelatin,
and phospholipids for liposomes, and abiotic substances,
including various polymers and solid metal containing
nanoparticles. The potential interaction of these nanoparti-
cles with tissues and cells is under investigation, but there
appears to be both great promise and concern, depending
on whether the target is drug delivery or potential toxicity
[1]. One aspect of more adequately addressing emerging
concerns of nanomaterials is being able to properly charac-
terize both their core and surface properties, variables that
ultimately delineate many downstream phenomena found in
biologicalsystemsthathaveremainedelusiveinpublichealth
and environmental characterization.
Reliable information is needed to determine whether a
nanoparticle may provide beneﬁts, risks, or, as is usually the
case, both. In the analogous ﬁeld of chemical characteri-
zation, a typical means of gaining such information is to
compare a chemical to other chemicals with similar struc-
tures (known as quantitative structure activity relationships
(QSAR)). Unfortunately, QSAR treatment of chemicals has
its limitations. In order to estimate properties, there must be
asuﬃcientamountofdataregardingsimilarchemicals.MoreJournal of Biomedicine and Biotechnology 3
importantly, QSAR cannot account for unique diﬀerences in
even very similar compounds. For example, it is well known
that chemicals with identical formulas, but with diﬀerent
conﬁgurations (e.g., enantiomers), may either be eﬃcacious
or toxic as ingredients in medicines. Likewise, chiral com-
pounds with the same composition but diﬀerent handedness
[6]w i l lh a v ev e r yd i ﬀerent environmental persistence (e.g.,
theright-handedchiralmaytakeyearstobiodegradewhereas
the left-hand compound may degrade in a few weeks). While
QSAR methods have shown some applicability in the ﬁeld
of nanoparticle characterization, they certainly are not a
complete solution [7].
The typical means of gaining information about ADME,
aside from developed QSAR models and other tools for
predictingwhetherabulkmaterialorcompoundwillpresent
risks, is to conduct in vitro, in vivo, and, more recently,
in silico experimental methods. In vitro studies may look
at cellular activity in a petri dish whereas in vivo studies
may expose rats to the chemical ingredient and observe
eﬀects. In silico studies employ computational methods such
as genomic and proteomic studies, data mining, molecular
modeling, and quantitative structure activity relationships.
The pharmacokinetics/pharmacodynamics of a chemical or
its modiﬁed progeny must be understood in order to de-
termine how the particle and its components become bioa-
vailable. Similarly, a variety of accelerated degradation stud-
ies can be performed on varied core-surface combinations
by using biomimetics methods (i.e., lung-on-a-chip technol-
ogy) and employing models tailored for nanomaterial char-
acterization properties such as the chirally perturbed particle
in a box model (CPPIB) [8] and other core-surface models.
Subsequently, morphology size domain optimization can be
completed via microscopy and chromatography specialists
and methods. These studies fully integrate a variety of vital
activities, research streams, and facilities to take on a major
emerging challenge for this novel class of materials, from
both a modeling and characterization perspective.
While the high degree of overlap in environmental,
health, and safety nanoparticle research promotes the con-
solidation of the ﬁelds into one area, the diﬀerences in on-
tology between the ﬁelds is a signiﬁcant impediment. Often,
diﬀerent terminology is used to describe similar phenomena
or homonyms for diﬀerent phenomena [9]. An example of
the former is the terminology employed for very small parti-
cles (<100nmdiameter).Aerosolresearcherscallthemultra-
ﬁnes. Nanotechnologists and material scientists call them
nanoparticles. Aquatic biologists and chemists call them
colloids. Soil scientists call them clay textures. An example
of the latter is the “E” in ADME. Biomedical researchers
usually consider it to be excretion whereas environmental
toxicologists usually consider it to be elimination. Another
example is the use of adsorption by physicists and engineers
versus its use by ADME researchers.
Such ontological diﬀerences typically lead to greater
segregation of researchers and reduce cross-ﬁeld integration
of similar research streams. Such segregation may lead to
underutilization or slower incorporation of important dis-
coveries made by specialists in either the health or the envi-
ronmentalspecialtyofnanoresearchandtherebyimpedethe
advancementofnanoscience.Inthiseﬀort,weinvestigatethe
growth of nanoparticle ADME research using bibliometric
techniques to visualize nature of growth, gaps in study, and
the isolation of research streams in the hope that the pressing
issues in the ﬁeld can be identiﬁed leading to a cohesive and
comprehensive body of nanoparticle ADME research.
2. Methods
2.1. Corpus Selection. To obtain a knowledge concerning the
state of research in nanoparticle ADME, we sought to obtain
the corpus of relevant peer-reviewed literature by search-
ing two databases: the Web of Knowledge (WoK) and Pub-
Med (http://www.PubMed.org/). These two databases pro-
vide a comprehensive collection of peer-reviewed literature
citations related to nanoparticle ADME properties. Other
databases containing unreviewed publications on the topic
were omitted to ensure the integrity of the literature corpus.
Collecting the full set of the literature related to na-
noparticle ADME research involved integration of several
queries with Boolean logic. Thankfully, such logic is simple
to form using the query engines available through the Web
of Knowledge (WoK) advanced search interface and PubMed
title ﬁlters. The primary limitation in accessing the appropri-
ate articles was due to diﬀerence in the annotation of articles
as being related to ADME. In order to collect a corpus that
we felt covered the relevant literature space, we were forced
to include several terms related to ADME, pharmacokinetic
modeling, or degradation. The inclusion of nano-related
terms and toxicity was more facile. The respective queries
shown in Table 2 retrieved a total of 1802 and 630 references
from WoK and PubMed.
2.2. Bibliometric Techniques. Using the “Analyze Results”
section of Web of Science (WoS) found within WoK (Web
of Knowledge) various reports (related to WoS subject
heading domains, authors, countries, dates, journal titles,
etc.) were generated as a csv ﬁles for export into various
graphing applications. For the sake of this paper, we have
exported the reports related to histograms of (a) timeline,
(b) WoS subject heading, (c) journal title, and (d) country
of origin and have imported (b) and (d) into Many Eyes
(http://www.ManyEyes.com/) to create a bubble-plot and a
geographical map representation of the data, respectively.
Graphs for (a) and (c) were generated in Excel (Microsoft)
(see Figures 2–5).
Many Eyes is an open-access Web 2.0 data visualization
(orvisualanalyticstoolbox)providedanddevelopedbyIBM.
We imported the domain-speciﬁc corpus of interest into
ManyEyesandusedthePhraseNetvisualizationoption with
Term 1 and Term 2 word structure map as an example (see
Figure 6).
Exporting the WOS reference list (plus cited references)
as a text ﬁle and importing into HistCite, we generated a
“histiograph” or timeline that contains information of im-
pact factor (circle size scaled to impact factor) as well as
linkages between citations within the speciﬁc collection or
corpus (see Figure 7).4 Journal of Biomedicine and Biotechnology
Table 2: Queries used to obtain the studied literature corpus.
Database Query Record count
ISI’s Web of Knowledge
(http://wokinfo.com/)
TI = (nano∗ OR nanotox∗)A N D
1802 references
TS = ((pharmacokinetic∗ OR toxicokinetic∗ OR disposition OR
distribution OR ADME OR pbpk OR environment∗)) AND TS = (toxic∗)
Timespan = All Years
Databases = SCI-EXPANDED
Lemmatization = On
PubMed
(http://www.PubMed.org/)
(Tissue distribution OR biodistribution OR dosimetry OR
pharmacokinetics OR dermal OR oral OR inhalation OR uptake OR
absorption OR route OR metabolism OR accumulation OR clearance OR
renal OR hepatic OR excretion OR elimination) AND (nano∗ OR
ultraﬁne∗)
630 references
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Figure 1: The distribution by year of the 1802 publications doc-
umented in the Web of Knowledge (WoK—see Table 2). The
exponential growth continued throughout the decade ending in
2010. The drop in 2011 is an artifact due to partial year reporting.
3. Results andDiscussion
Bibliometric analysis was carried out on two corpora of the
literature resulting from searching of PubMed and the Web
of Knowledge (WoK) as described in Section 2.
3.1. Growth of Nanoparticle ADME. Figure 1 delineates the
growth in the number of publication related to ADME,
toxicity, and nanoparticles within the WoK. It can clearly
be seen that a drastic increase in publication started near
2002. In the eleven years prior to 2002, only 60 articles
were recorded in the WoK. Since, 1742 articles related to
nanoparticle ADME have been documented. To better un-
derstand the structure of this growth, we examined the time
period before and after this critical point when research
started to become mainstream.
We ﬁrst sought to determine whether the growth evident
from Figure 1 was driven in a small number of locations,
or if the study of nanoparticle ADME had spread from
isolated research centers broadly throughout the world.
Figure 2 shows the distribution of publications by country
of authorship for publication before and after 2002. While
the study of ADME properties of nanoparticles may have
originally been primarily segregated to industrialized coun-
tries (U.S., Canada, Western Europe, China, and Japan), it
has since been picked up throughout the world. A large
number of the world’s nations have produced research
focused on nanoparticle ADME. This global expansion of
research highlights the importance of the topic and the
general concern regarding nanoparticles.
The global spread of interest in nanoparticles could be
caused by either an increased interest in the topics studied
prior to the spread or an integration of nanoparticle research
into more topics. To determine which one described the
observed growth, we examined the subject areas for which
ADME nanoscale research was being carried out (Figure
3). It is clear that the medical ﬁeld drove the initial push
of nanoparticle ADME research. Pharmaceutical scientists
intent on controlling the release of medication pioneered
the study of nanoparticle delivery systems. The topic of
pharmacology/pharmacy contained over 50% of all pub-
lication prior to 2002. Upon investigating the journals in
which this research is commonly published, the importance
of the medical ﬁeld on the inception of nano-ADME became
more apparent (Figure 4). While publication is evenly spread
amongst the represented journals prior to 2002, all of the
journals are related to medical research. However, as this
area has matured, environmental sciences and toxicology
have shown marked growth. As seen in Figure 3, the number
of articles related to these two ﬁelds has caught up to
the number of publications related to medical applications.
In addition, the number of specialty areas and topics
has expanded. Both of these aspects of growth are also
apparentwhenlookingthroughthesetofjournals(Figure 4).
EnvironmentalScience&Technologyhasbecomethejournal
containing the most ADME nanoscale research evokingJournal of Biomedicine and Biotechnology 5
1991–2002
2003–2011
Visualization using many-eyes.com
Datasource: WOS, ISI Thomson Reuters 
Figure 2: The distribution of publications by country of origin in the time before and after the boom of nanoresearch. The maps show
record for the years prior to and after 2002. Prior to 2002 the majority of novel nano research was originally centralized in North America
and certain pockets of Europe whereas China was a major source for manufacturing. More recently China has become a major player in
research (not just manufacturing) and global eﬀorts spanning South America, to portions of Asia and Africa, and Eastern Europe have also
become evident alongside North America’s eﬀort. (see Table 2: total of 1802 record corpus from WoK analyzed by country of origin in WoK
and exported to http://www.ManyEyes.com/).
1991–2002
2003–2011
Datasource: WOS, ISI Thomson Reuters 
Visualization using many-eyes.com
Figure 3: The distribution of publications by subject area in the time before and after the boom of nano research (i.e., ∼2002) as classiﬁed
by WoK subject heading citation analysis of 1802 records (see Table 2).
theformerwhiletheincreaseinspecialtyjournalsstressesthe
latter.
3.2.KeyTerms. Whileitisclearthatthestudyofnanoparticle
ADME has grown, we considered it important to understand
which physiological processes were being the most exam-
ined. By studying the frequency of terms contained within
the collected nanoparticle ADME corpus of the literature,
insights into the extent of the covered ﬁelds were obtained.
We sought to uncover such information based on the corpus
of the literature we had collected.
First we looked at the frequency of keywords associated
with ADME in the literature base. Figure 5 displays these
keyword frequencies and highlights important portions of
the ADME process that are understudied. Uptake was the
moststudiedpartofnanoparticleADME,particularlyuptake
via oral and inhalation routes. However, dermal uptake
was less studied though this is a highly probable form of
environmental exposure. Additionally, the study of nanopar-
ticleuptakehasgreatlyoutpacedresearchintotheotherparts
of the ADME process: metabolism and elimination. This
lack of focus on vital elements of the physiological processes
responsible for actual dose at targeted tissues points to areas
of the ﬁeld that must be further developed.
Taking the abstracts for our set of articles, we then
completed a two-word PhraseNet analysis. The resulting
network of terms displayed in Figure 6 provides an excellent
summaryofconceptswithintheareaofnanoparticleADME.
Key aspects of the research such as engineered properties,
exposure types, size domains, key organs, and the underlying
research domains are all evident. Such graphics provide a
high-level view of the principles connected within the ﬁeld.
It is clear from Figure 6 that the study of the environmental
impact of nanoparticles has driven a large part of the
increased growth in nanoparticle ADME research, having
become the key term centralized in the network.6 Journal of Biomedicine and Biotechnology
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3.3. Publication Segregation. Unfortunately, the large
amount of nanoparticle ADME research does not necessarily
mean that it is a cohesive area of research. In fact, the large
increase in the number of journals accepting ADME research
on nanoparticles (as seen in Figure 4) provides evidence to
the contrary. As the ﬁeld has grown, it has become harder
to ﬁnd and access all the publications that are relevant
to the topic. Figure 7 displays the citation analysis of the
WoK publication list and indicates segregation has occurred
within the corpus of research. While some distinct lines of
research are starting to link to other lines, and there may be
some pivotal research articles that have both impact factor
in addition to memory between years (looking at zoom in
of top 23 articles), there is overall a lack of crosstalk between8 Journal of Biomedicine and Biotechnology
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Figure 7: Histiograph of WoK corpus of the nano-ADME literature from Table 2, generated using the HistCite package (http://thom-
sonreuters.com/products services/science/science products/a-z/histcite/).
specialties and research eﬀorts. We found it surprising that
the majority of high-impact citations connected to none
of the previous high-impact citations with the ﬁeld. What
is also apparent from the high-impact internal citation
histiograph is that the domains of nanobiomedicine (i.e.,
therapeutics) and nanotoxicology (adverse eﬀects, and large
contribution to environmental characterization) emerged
over time. While nanobiomedicine dominated the high-
impact citations prior to 2002, the high-impact citations
after 2002 were primarily focused on environmental health
and nanotoxicology eﬀorts.
4. Conclusions
Knowledgetoolsareeﬀectiveinidentifyingtrendsinresearch
related to nanomaterials [10]. This study described how the
research landscape has changed rapidly for health and envi-
ronmental research. Ten years ago, the medical community
dominated ADME nanoscale research almost exclusively.
Five years ago, the environmental community surpassed
medical research in terms of volume of work and number
of journals accepting papers in this area. With the growth of
researchfocused ondiﬀerent aspects fornanoparticle ADMEJournal of Biomedicine and Biotechnology 9
and the number of specialty subject in the ﬁeld, there is a
c l e a rn e e df o re ﬀective communication amongst researchers.
The development of a blended ontology agreed upon by all
ﬁelds interested in nanoparticle ADME properties could ease
this communication.
Based on the key term frequencies, there is a void in the
literature that indicates some of the most important aspects
of the ADME process for nanoparticles are understudied.
We suggest that these areas be addressed more speciﬁcally
in future research by environmental, health, and safety re-
searchers. In order to reach a point where the pharmacoki-
netics of nanoparticles are truly understood, study of uptake
properties is insuﬃcient.
Finally, this study highlights the segregation of the cur-
rent literature of what should be compatible academic and
professional disciplines engaged in research on this topic.
The lack of connectivity within the histiograph of the nano-
ADME literature seems to indicate that eﬀective commu-
nication may not be occurring. It is important to discover
whether this is a common aspect of histiographs for other
ﬁelds of research or a unique feature of nano-ADME re-
search. Further study of the eﬀects of ontology (or lack
of consistent language) on research connectivity should be
carried out in this ﬁeld as well as others. While the problem
appears to be lessening with key papers connecting the
segregated ﬁelds, the results lend credence to the hypothesis
that current diﬀerences in language may be impeding com-
munication, and that blending terminology to avoid ambi-
guity could enhance collaborations among the health and
environmental disciplines.
Disclaimer
This paper was reviewed by EPA and approved for publi-
cation but does not necessarily reﬂect oﬃcial agency policy.
The appearance or absence of product, services, companies,
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